Generate a tailored SOP for Dr. Mark Yarmarkovich. Improve your application with a focused, well-structured draft.
Mark Yarmarkovich is an Assistant Professor at the Perlmutter Cancer Center, specializing in Cancer Immunotherapy and various interdisciplinary fields such as genomics, proteomics, and computational biology. His lab focuses on the development of personalized immunotherapies, particularly CAR T cells and TCRs, for cancer patients. His work encompasses target discovery to clinical applications, aiming to identify novel tumor-specific targets and engineering immune receptors. Notably, he has pioneered a new class of peptide-centric CAR T cells that significantly broaden the landscape of immunotherapeutically targetable options, with preclinical models showcasing the potential to completely eliminate tumors. Currently, Mark's research is expanding into new technologies that facilitate the development of personalized immunotherapies, with several projects underway in immunotherapy target discovery and CAR T cell development. He aims to translate these innovations into clinical trials by 2024/5, contributing to advancements in treating cancer patients with previously undruggable proteins.
Open Program in Biomedical Sciences (Vilcek Institute) covers departments like Biochemistry, Pathology, Neuroscience, Microbiology, etc.